← Product Code [HHK](/submissions/OB/subpart-b%E2%80%94obstetrical-and-gynecological-diagnostic-devices/HHK) · K991895 # RAMPIPELLA, SINGE PORT (720196) & WEDGE-SHAPED PORT (720217) (K991895) _Ri Mos. S.R.L. · HHK · Aug 12, 1999 · Obstetrics/Gynecology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/OB/subpart-b%E2%80%94obstetrical-and-gynecological-diagnostic-devices/HHK/K991895 ## Device Facts - **Applicant:** Ri Mos. S.R.L. - **Product Code:** [HHK](/submissions/OB/subpart-b%E2%80%94obstetrical-and-gynecological-diagnostic-devices/HHK.md) - **Decision Date:** Aug 12, 1999 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 884.1175 - **Device Class:** Class 2 - **Review Panel:** Obstetrics/Gynecology ## Indications for Use For endometrial sampling for histologic biopsy of the uterine mucosal lining. ## Device Story The GINRAM® Rampipella is a sterile, single-use, disposable endometrial suction curette. It is used by clinicians to obtain tissue samples from the uterine mucosal lining for histologic biopsy. The device operates via manual negative pressure to aspirate tissue. It is intended for use in a clinical setting. By providing a method for tissue collection, it assists healthcare providers in diagnosing uterine conditions through histological analysis. ## Clinical Evidence Comparative clinical performance evaluations were conducted to assess the device's ability to collect adequate histological grade tissue. Results demonstrated that the device successfully collected a sufficient amount and grade of tissue for biopsy. No adverse events were reported during the evaluation. ## Technological Characteristics Sterile, single-use, disposable endometrial suction curette. Operates via negative pressure. Form factor is a manual suction device designed for uterine tissue sampling. ## Regulatory Identification An endometrial suction curette is a device used to remove material from the uterus and from the mucosal lining of the uterus by scraping and vacuum suction. This device is used to obtain tissue for biopsy or for menstrual extraction. This generic type of device may include catheters, syringes, and tissue filters or traps. ## Predicate Devices - Unimar Pipelle® Pipelle de Cornier™ Endometrial Suction Curette - Vabra Aspirator® (Berkeley Medevices, Inc.) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ AUG 12 12 Section 8 510 (k) Summary K941895 This summary of 510 (k) safety and effectiveness information is submitted in accordance with the requirements of the Safe Medical Devices Act of 1990 and 21 C.F.R. §807.92. - The submitter of this premarket notification is: 1 . James M. Delaney Associate EXPERTech Associates, Inc. 100 Main Street, Suite 120 Concord, MA 01742 Tel: (978) 371-0066 Fax: (978) 371-1676 This summary was prepared on June 1, 1999. - 2. The name of the RI.MOS. s.r.l. device is Rampipella. The common name is curette, and the classification name is Endometrial suction curette. - The above device is substantially equivalent to the Unimar Pipelle® Pipelle de 3. Cornier™ Endometrial Suction Curette distributed by CooperSurgical and the Vabra Aspirator® distributed by Berkeley Medevices, Inc. - The RI.MOS. s.r.l. curette operates by negative pressure and is a sterile, single-use, 4. disposable device. - న. The device is intended for endometrial sampling for histologic biopsy of the uterine mucosal lining. - 6. The technological characteristics are the same or similar to those found with the marketed predicate device. - 7. Comparative clinical performance evaluations were conducted to establish adequate histological grade tissue collection. Results showed sufficient amount and grade of tissue collection, and no adverse events were reported. ﺎ {1}------------------------------------------------ Image /page/1/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three lines forming its body and wings. The eagle is facing to the right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the eagle. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 AUG 1:2 1999 RI. MOS. S.r.I. c/o Mr. James M. Delaney Associate EXPERTech Associates Inc. 100 Main Street. Suite 120 Concord, MA 01742 Dear Mr. Delaney: Re: K991895 GINRAM® Rampipella Dated: June 1, 1999 Received: June 3, 1999 Requiatory Class: II 21 CFR §884.1175/Procode: 85 HHK We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21. Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in requlatory action. In addition. FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. This letter will allow you to begin marketing your device as described in your 510(t) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), piease contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html". Sincerely yours, CAPT Daniel G. Schultz, M.D. Acting Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ## Indications for Use Statement 510(k) Number K 991895 (if known) ## Device Name RI. MOS. s.r.l. GINRAM® Rampipella Indications for Use For endometrial sampling for histologic biopsy of the uterine mucosal lining. ## PLEASE DO NOT WRITE BELOW THIS LINE · CONTINUE ON ANOTHER PAGE IF NEEDED Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use _ (Per 21 CFR 801.109) OR Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________ Noril G. Slegman (Division Sign-Off) (Division of Reproductive, Abdominal, ENT, and Radiological Devices 895 510(k) Number. --- **Source:** [https://fda.innolitics.com/submissions/OB/subpart-b%E2%80%94obstetrical-and-gynecological-diagnostic-devices/HHK/K991895](https://fda.innolitics.com/submissions/OB/subpart-b%E2%80%94obstetrical-and-gynecological-diagnostic-devices/HHK/K991895) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com